Related Experiment Video
Updated: Aug 1, 2026

Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 6, 2013
An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril
Magdalena I Ivanova1, Michael R Sawaya, Mari Gingery
1Howard Hughes Medical Institute and University of California-Department of Energy Institute of Genomics and Proteomics, Box 951570, University of California, Los Angeles, CA 90095, USA.
Abstract:
In humans suffering from dialysis-related amyloidosis, the protein beta2-microglobulin (beta2M) is deposited as an amyloid; however, an amyloid of beta2M is unknown in mice. beta2M sequences from human and mouse are 70% identical, but there is a seven-residue peptide in which six residues differ. This peptide from human beta2M forms amyloid in vitro, whereas the mouse peptide does not. Substitution of the human peptide for its counterpart in the mouse sequence results in the formation of amyloid in vitro. These results show that a seven-residue segment of human beta2M is sufficient to convert beta2M to the amyloid state, and that specific residue interactions are crucial to the conversion. These observations are consistent with a proposed Zipper-spine model for beta2M amyloid, in which the spine of the fibril consists of an anhydrous beta-sheet.
Insights
A specific seven-residue peptide in human beta2-microglobulin (beta2M) drives amyloid formation. This finding is crucial for understanding dialysis-related amyloidosis and beta2M
Area of Science:
- Biochemistry
- Molecular Biology
- Medical Research
Background:
- Dialysis-related amyloidosis in humans involves beta2-microglobulin (beta2M) amyloid deposition.
- Beta2M amyloid is not observed in mice, despite high sequence homology with human beta2M.
Purpose of the Study:
- To identify the specific regions of beta2M responsible for amyloid formation.
- To elucidate the molecular mechanisms underlying beta2M amyloidogenesis.
Main Methods:
- Comparative sequence analysis of human and mouse beta2M.
- In vitro amyloid formation assays using synthetic peptides.
- Site-directed mutagenesis to substitute human and mouse peptide segments.
Main Results:
- A seven-residue peptide segment in human beta2M, differing significantly from its mouse counterpart, was identified.
- This human peptide segment readily formed amyloid in vitro, while the mouse segment did not.
- Replacing the mouse segment with the human segment in mouse beta2M induced in vitro amyloid formation.
Conclusions:
- A specific seven-residue segment of human beta2M is sufficient to induce amyloid formation.
- Key residue differences within this segment are critical for beta2M conversion to the amyloid state.
- These findings support the Zipper-spine model for beta2M amyloid structure.
Related Concept Videos
Protein Organization
Protein Folding
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme can...
Globular and Fibrous Proteins
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

